Related Experiment Video
Updated: May 5, 2026
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Biliary atresia: will blocking inflammation tame the disease?
Kazuhiko Bessho1, Jorge A Bezerra
1Pediatric Liver Care Center and Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center and the Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio 45229-3031, USA.
Insights
Biliary atresia, a childhood liver disease, obstructs bile ducts. Early surgery helps bile flow, but immune system involvement may drive disease progression, necessitating new therapies.
Area of Science:
- Pediatric Hepatology
- Immunology
- Gastroenterology
Background:
- Biliary atresia is the leading childhood cholangiopathy.
- Complete obstruction of extrahepatic bile ducts requires prompt hepatoportoenterostomy for bile drainage restoration.
- Despite surgery, intrahepatic bile duct injury and progressive cholangiopathy can lead to cirrhosis.
Purpose of the Study:
- To explore the role of the immune system in biliary atresia pathogenesis.
- To discuss how clinical phenotyping and staging inform therapeutic strategies.
- To identify directions for developing novel therapies to halt disease progression.
Main Methods:
- Review of clinical and mechanistic data on biliary atresia.
- Analysis of immune system involvement in bile duct injury.
- Discussion of clinical trial design informed by disease staging.
Main Results:
- Immune system targeting of duct epithelium is increasingly implicated in bile duct injury.
- Disease progression varies, potentially linked to clinical forms and pathology staging.
- Clinical phenotyping and mechanistic research offer insights into therapeutic targets.
Conclusions:
- Understanding immune-mediated bile duct injury is crucial for biliary atresia management.
- Multidisciplinary approaches combining clinical and basic research are essential.
- Development of immunomodulatory therapies may offer new treatment avenues.
Abstract:
Biliary atresia is the most common cholangiopathy of childhood. With complete obstruction of segments or the entire length of extrahepatic bile ducts, the timely pursuit of hepatoportoenterostomy is the best strategy to restore bile drainage. However, even with prompt surgical intervention, ongoing injury of intrahepatic bile ducts and progressive cholangiopathy lead to end-stage cirrhosis. The pace of disease progression is not uniform; it may relate to clinical forms of disease and/or staging of liver pathology at diagnosis. Although the etiology of disease is not yet defined, several biological processes have been linked to pathogenic mechanisms of bile duct injury. Among them, there is increasing evidence that the immune system targets the duct epithelium and disrupts bile flow. We discuss how careful clinical phenotyping, staging of disease, and basic mechanistic research are providing insights into clinical trial designs and directions for development of new therapies to block progression of disease.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:20Cholecystitis
01:21Chronic Pancreatitis II: Pathophysiology